Skip to main navigation Skip to search Skip to main content

Early response does not predict outcome in children and adolescents with chronic myeloid leukaemia treated with high-dose imatinib

  • Fiorina Giona
  • , Giuseppe Saglio
  • , Michelina Santopietro
  • , Giuseppe Menna
  • , Maria Caterina Putti
  • , Concetta Micalizzi
  • , Grazia Iaria
  • , Nicola Santoro
  • , Saverio Ladogana
  • , Rosamaria Mura
  • , Roberta Burnelli
  • , Caterina Consarino
  • , Carlo Cosmi
  • , Maria Luisa Moleti
  • , Anna Leszl
  • , Francesca Tucci
  • , Mauro Nanni
  • , Daniela Diverio
  • , Andrea Biondi
  • , Franco Locatelli
  • Robin Foà
  • University of Rome La Sapienza
  • University of Turin
  • Azienda Ospedaliera Santobono Pausillipon
  • Azienda Ospedaliera di Padova
  • IRCCS Istituto Giannina Gaslini - Genova
  • Azienda Ospedaliera Bianchi-Melacrino-Morelli
  • Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
  • IRCCS Ospedale Casa Sollievo della Sofferenza - San Giovanni Rotondo (FG)
  • AO Brotzu
  • Sant'Anna University Hospital of Ferrara
  • Azienda Ospedaliera Pugliese-Ciaccio
  • Ospedale di Sassari
  • University of Milan - Bicocca

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)895-898
Number of pages4
JournalBritish Journal of Haematology
Volume180
DOIs
Publication statusPublished - 2018

Keywords

  • childhood leukaemia
  • CML
  • tyrosine kinase inhibitors
  • outcome
  • early response

Cite this